Remove 2021 Remove Diagnose Remove Disease Remove Radiographer
article thumbnail

Radiologists Must Monitor Novel Alzheimer’s Treatment Side Effect

Imaging Technology

Alzheimer disease is a progressive, irreversible brain disorder that slowly degrades memory and cognitive function. While previous treatment methods focused on addressing Alzheimer disease symptoms, recent approvals of monoclonal antibodies have provided a path to target the underlying disease itself. In June 2021, the U.S.

article thumbnail

FDA approves Bayer’s Ultravist (iopromide) Injection for Contrast-enhanced Mammography

Imaging Technology

The approval expands upon Bayer's focus on breast imaging, with a portfolio that also includes Gadavist (gadobutrol) injection, a gadolinium-based contrast agent approved for use with MRI ( Magnetic Resonance Imaging ) to assess the presence and extent of malignant breast disease in adult patients. RadioGraphics 2019 39:7, 1907-1920.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging

Imaging Technology

The Company received 510(k) clearance to market its single-source X-ray device, known as the Nanox Cart X-Ray System, in April 2021. Medical imaging is essential for detecting, diagnosing, and managing disease, guiding treatment decisions for improved health outcomes.

article thumbnail

Less is More. Again: Speed of IV Fluid Administration in Pancreatitis (WATERFALL Trial)

REBEL EM

Population: Adult patients > 18 years of age diagnosed with acute pancreatitis based on the Revised Atlanta Classification (requires 2 of 3: typical abdominal pain, serum amylase or lipase level higher than 3 times the upper limit of normal or signs of acute pancreatitis on imaging) that presented within 24 hours of pain onset.

Disease 52